# Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial

> **NCT04333823** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Dapagliflozin 5mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04333823
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-11
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04333823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04333823, "Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04333823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*